Article
Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2R allele.
International journal of cancer - 1 Jan 2016
Meulendijks Didier, Jacobs Bart A W, Aliev Abidin, Pluim Dick, van Werkhoven Erik, Deenen Maarten J, Beijnen Jos H, Cats Annemieke, Schellens Jan H M
Abstract excerpt
The fluoropyrimidines act by inhibiting thymidylate synthase (TS). Recent studies have shown that patients' risk of severe fluoropyrimidine-associated toxicity is affected by polymorphisms in the 5'-untranslated region of TYMS, the gene encoding TS. A G>C substitution in the promoter enhancer region of TYMS, rs183205964 (known as the 2RC allele), markedly reduces TS activity in vitro, but its clinical relevance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
